To the Editor: Dr Kamstrup and colleagues1 assessed the association between elevated lipoprotein(a) and risk of myocardial infarction using data from the Copenhagen General Population Study (CGPS), the Copenhagen City Heart Study, and the Copenhagen Ischemic Heart Disease Study. We believe that several limitations were not adequately addressed in their article.
Jones SR, Blumenthal RS. Lipoprotein(a) Measurement and Determining Risk of Myocardial Infarction. JAMA. 2009;302(15):1645-1646. doi:10.1001/jama.2009.1483